Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

Traditionally, cancer diagnosis and prognosis rely heavily on histopathological examination, where tissue morphology is evaluated under the microscope. However, the molecular ...

Earlier this week, Krystal Biotech reported positive interim data from the highest-dose cohort of its Phase 1 CORAL-1 trial, ...

We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...

Much of pancreatic cancer’s evasive and deadly nature may come down to low levels of one gene. In A Nutshell Early detection, ...

When pistachio hulls split before the nuts are harvested, insects and fungi can get inside, damaging the nut, costing farmers ...

The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...

The clinical-stage genetic medicine company reported that LX2020 was generally well tolerated across ten participants, with ...

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...